June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer
Feb 1, 2025, 07:13

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared an article on X he and his colleagues authored:

“Pleased to share P2 results of futibatinib for FGFR2-amplified gastric cancer: ORR 17.9%. Shows some activity but underscores need for better options. Eagerly awaiting P3 chemo + bemarituzumab data.”

Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications

Authors: Taroh Satoh et al.

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer